Get the Stockscreener App
568.99
0.29%
-3.72
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $568.99, with a volume of 340.46K.
It is down -0.29% in the last 24 hours and up +4.66% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
See More
Previous Close:
$572.71
Open:
$574.78
24h Volume:
340.46K
Relative Volume:
0.18
Market Cap:
$219.06B
Revenue:
$42.88B
Net Income/Loss:
$6.34B
P/E Ratio:
34.42
EPS:
16.53
Net Cash Flow:
$7.27B
1W Performance:
-4.47%
1M Performance:
+4.66%
6M Performance:
-2.78%
1Y Performance:
+3.39%
1-Day Range:
$569.30
$577.48
1-Week Range:
$568.37
$600.40
52-Week Range:
$493.30
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
569.30 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
208.77 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.05 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
463.58 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
209.08 | 36.97B | 15.32B | 1.41B | 1.96B | 7.62 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher Scientific's isotope-free elemental analyser - Mining Magazine
Sequencing Reagents Industry Eyes $15.84 Billion Valuation by 2030Thermo Fisher Scientific, Abzena, Illumina, QIAGEN, and Pacific Biosciences of California Lead the Competition - Yahoo Finance
Multiomics Market 2024 Size, Global Report till 2031 | Thermo Fisher Scientific Inc., Illumina, Inc., Becton Dickinson - openPR
How Thermo Fisher Achieved 100% Renewable Energy in Europe - Sustainability Magazine
Thermo Fisher looks to optimise sampling strategy with new solution - International Mining
DNA Microarray Market to Grow with Leading Key PlayersThermo - openPR
Thermo Fisher Powers Up With Solar: Partners With X-ELIO To Achieve 100% Renewable Electricity In Europe - SolarQuarter
Analytical Standards Market to Grow by USD 657.8 Million (2024-2028) with Rapid Growth in the Life Science Industry Boosting the Market, Report on AI Impact on Market TrendsTechnavio - Yahoo Finance
Exosomes Market Future Business Opportunities 2025-2032 | - openPR
Thermo Fisher Scientific Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Thermo Fisher: Powering Sites with 100% Renewable Energy - Energy Digital
Thermo Fisher Scientific announces 10-year VPPA with X-ELIO - European Pharmaceutical Manufacturer
Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Alopecia Areata - Business Wire
Ultra-High-Performance Liquid Chromatography Pumps Market Report 2024: Opportunities in Miniaturization and Portability, Customization and Modularity, & Rising Investments in R&D - GlobeNewswire Inc.
Activation Analysis Market Deep Research Report with Forecast - openPR
Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch
Fungal Keratitis Treatment Market Growth By 2031 | Harrow Inc., - openPR
Thermo Fisher continues viral vector withdrawal; lays off 300 employees - Yahoo Finance
Beach Investment Counsel Inc. PA Has $2.78 Million Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Compass Capital Management Inc. - MarketBeat
Renewable Energy Milestone: Thermo Fisher's Strategic Solar Deal Transforms European Operations - StockTitan
Calamos Wealth Management LLC Sells 18,727 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
abrdn plc Sells 9,482 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc: An Exploration into Its Intrinsic Value - Yahoo Finance
Resonant Capital Advisors LLC Has $733,000 Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Stock Yards Bank & Trust Co. Reduces Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Sodium Chlorate Market to surpass USD 7.2 Billion by 2034, Says Global Market Insights inc. - GlobeNewswire Inc.
Freeze-drying Equipment Market Set to Witness Significant Growth by 2025-2032: Telstar, Thermo Fisher - EIN News
Thermo Fisher Scientific’s SWOT analysis: stock outlook amid market shifts By Investing.com - Investing.com Nigeria
Hundreds face layoffs as biotech company cuts jobs in Eastern Mass. - MassLive.com
Thermo Fisher Scientific's SWOT analysis: stock outlook amid market shifts By Investing.com - Investing.com Australia
Thermo Fisher again trims workforce at Massachusetts viral vector sites - FirstWord Pharma
Thermo Fisher cuts 300 Massachusetts jobs - NBC Boston
Thermo Fisher’s latest job cuts impact hundreds of Massachusetts employees - The Business Journals
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $655 From $645, Keeps Buy Rating - Marketscreener.com
Stephens Adjusts Price Target on Thermo Fisher Scientific to $660 From $640, Keeps Overweight Rating - Marketscreener.com
Thermo Fisher Scientific's SWOT analysis: stock outlook amid market shifts - MSN
Thermo Fisher's layoff spree continues with 300 dismissals in Massachusetts - NewsBreak
Scotiabank Forecasts Strong Price Appreciation for Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Benzinga
Raymond James Reaffirms Outperform Rating for Thermo Fisher Scientific (NYSE:TMO) - MarketBeat
Rheos Capital Works Inc. Purchases 8,300 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher to cut 300 jobs in Cambridge, Plainville - The Boston Globe
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by JB Capital LLC - MarketBeat
Chicago Capital LLC Has $20.59 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Abner Herrman & Brock LLC Has $9.13 Million Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
HHM Wealth Advisors LLC Has $302,000 Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific (NYSE:TMO) Posts Quarterly Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
Thermo Fisher Scientific Reports Strong Financial Results for Fourth Quarter and Full Year 2024WALTHAM, Mass. (January 30, 2025) – Thermo Fisher Scientific Inc. (NYSE: TMO) announced its financial results for the fourth quarter and full year ended De - Defense World
Leerink Partnrs Issues Negative Estimate for TMO Earnings - Defense World
Thermo Fisher Scientific (NYSE:TMO) Price Target Raised to $678.00 - Defense World
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.56%
0.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):